Your session is about to expire
← Back to Search
Psychosocial Education + Heart Health Yoga for Ischemic Heart Disease
N/A
Waitlist Available
Led By Meghana G. Halkar, MBBS
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 8 weeks, 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if adding Heart Health Yoga to standard cardiac rehabilitation will improve wellbeing for patients with ischemic heart disease.
Who is the study for?
This trial is for adults aged 18-65 with ischemic heart disease who can consent to participate. They must have a computer and smartphone to access study materials and be willing to use the Fitbit app. It's not for those on antipsychotics, with exercise-limiting injuries, or active psychiatric conditions like bipolar disorder or schizophrenia.
What is being tested?
The trial tests if adding Heart Health Yoga (HHY) Program to standard cardiac rehab improves wellbeing in patients with narrowed heart arteries. Participants will engage in psychosocial education and yoga designed specifically for heart health.
What are the potential side effects?
Since this trial involves yoga and educational components rather than medication, side effects may include muscle soreness or strain from physical activity. Psychological discomfort could also occur due to changes in routine or confronting health issues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6 weeks, 8 weeks, 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 8 weeks, 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in health-related quality of life
Secondary study objectives
6 minute walk test distance measured in meters
AM cortisol
Blood pressure
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cardiac rehabilitation with standard psychosocial care plus Heart Health YogaExperimental Treatment2 Interventions
Subjects will participate in 12-weeks of cardiac rehabilitation with standard psychosocial care plus Heart Health Yoga
Group II: Cardiac rehabilitation with standard psychosocial careActive Control1 Intervention
Subjects will participate in 12-weeks of cardiac rehabilitation with standard psychosocial education component
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,326 Previous Clinical Trials
3,059,442 Total Patients Enrolled
28 Trials studying Coronary Artery Disease
27,233 Patients Enrolled for Coronary Artery Disease
Meghana G. Halkar, MBBSPrincipal InvestigatorMayo Clinic
Bryan J Taylor, PhDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
40 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Currently taking medication for mental illness.You are between 18 and 65 years old.You have a bone or muscle injury that limits your ability to exercise, or any other reasons that make exercise unsafe for you.You have ongoing mental health conditions like bipolar disorder, schizophrenia, or obsessive compulsive disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Cardiac rehabilitation with standard psychosocial care plus Heart Health Yoga
- Group 2: Cardiac rehabilitation with standard psychosocial care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger